David A. Siegel Nls Pharmaceutics Ltd. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.82 - $1.76 $18,696 - $40,128
-22,800 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.11 - $2.56 $4,995 - $11,520
-4,500 Reduced 16.48%
22,800 $25,000
Q3 2021

Nov 15, 2021
BUY
$2.29 - $3.14 $37,785 - $51,810
16,500 Added 152.78%
27,300 $68,000
Q2 2021

Aug 16, 2021
BUY
$2.91 - $4.12 $31,428 - $44,496
10,800 New
10,800 $34,000

About NLS Pharmaceutics Ltd.

NLSP Quotes by TradingView
  • Ticker NLSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,349,900
  • Market Cap $55.5M
  • Description
  • NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...
More about NLSP
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email